DAD Confide home HIV test kit fails GMPs for filter blood absorbency -- FDA warning letter.
This article was originally published in The Gray Sheet
Executive Summary
J&J CONFIDE HIV TEST KIT FAILS BLOOD ABSORBENCY TEST GMPs, FDA states in a warning letter delivered to Johnson & Johnson company Direct Access Diagnostics on May 28. FDA considers the home test kit adulterated in that it does not conform with the good manufacturing practice regs for medical devices as it pertains to the validation of blood tests; Confide also is considered misbranded because DAD did not submit information on the product required by the medical device reporting reg, FDA says. In addition, the company is cited for not collecting the required demographic information from Confide test kit users as mandated by the premarket approval application dated May 14, 1996. The warning letter was issued following an inspection of the company's facility in Bridgewater, New Jersey March 24 through April 4.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.